الفهرس 
Cerebravascular strokeOnly 14 pages are availabe for public view
 |  | from | 32 |  |  |
| | | from | 32 | | |
Abstract
Stroke occurs in 30.9 million individuals worldwide and is responsible
for ~4 million deaths every year. In the United States, it is the third
leading cause of death. The greatest burden of stroke, apart from death, is
serious long-term physical and mental disability. Stroke survivors often
experience physical handicap, depression, and cognitive dysfunction,
which together affect their daily functioning, quality of life, and
survival.(Giuseppe Mancia,2004)
Stroke is the largest single cause of disability in the UK. While tests
based upon biomarkers have been around for decades, interest in the
applications of biomarkers has increased greatly in recent years.
Biomarkers released into the blood stream following a stroke are useful
not only for understanding the pathogenesis of stroke, but also play a
significant role in the development of personalized medicine. The
efficacy of current clinical models and imaging techniques for the
diagnosis and prognosis of acute stroke could be improved when used in
conjunction with blood biomarkers (Nazeeha Hasan et al,2012)
The aim of this study is to explore the magnitude of (D dimer, Fibrinogen
and C- reactive protein) within 24 hours as biomarkers of acute ischemic
cerebral stroke and their relation to different ischemic stroke subtypes and
their impact on the short term outcome after 30 days.